migraines

With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Satsuma peels off staff, cutting head count by 36% to save cash while searching for a deal
Fierce Biotech
Wed, 03/29/23 - 09:37 am
Satsuma Pharmaceuticals
layoffs
migraines
STS101
Pfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packaging
USA Today
Fri, 03/17/23 - 10:18 am
Pfizer
Nurtec ODT
migraines
packaging
product recalls
Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK
Endpoints
Thu, 03/16/23 - 09:46 am
Pfizer
migraines
Royalty Pharma
Biohaven
zavegepant
Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval
BioSpace
Fri, 03/10/23 - 11:32 am
Pfizer
Biohaven
FDA
migraines
nasal spray
zavegepant
Zavzpret
Pfizer cites positive results on nasal spray migraine treatment
Medical Xpress
Thu, 02/16/23 - 08:09 pm
Pfizer
migraines
The Lancet
nasal spray
zavegepant
Satsuma in the red after 2nd phase 3 migraine flop spurs search for strategic alternatives
Fierce Biotech
Mon, 11/14/22 - 10:48 am
Satsuma Pharmaceuticals
clinical trials
migraines
STS101
intra-nasal drug delivery
Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight
Fierce Pharma
Thu, 11/10/22 - 10:12 pm
Eli Lilly
legal
migraines
Ajovy
patents
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Tue, 10/4/22 - 11:45 pm
Pfizer
Biohaven
migraines
epilepsy
Satsuma peels off fresh strip of long-term migraine study data ahead of planned FDA filing
Fierce Pharma
Mon, 09/26/22 - 10:57 am
Satsuma Pharmaceuticals
migraines
clinical trials
STS101
Setback at Lundbeck: CGRP migraine drug Vyepti hits expansion snag, but sales still doubled
Fierce Pharma
Thu, 08/18/22 - 12:32 pm
Lundbeck
earnings
migraines
CGRPs
Vyepti
AbbVie files Qulipta for chronic migraine prevention
Pharmaforum
Wed, 06/22/22 - 10:21 am
AbbVie
Qulipta
migraines
FDA
Zosano goes bankrupt after FDA rejects migraine drug delivery patch
Fierce Pharma
Tue, 06/7/22 - 10:07 am
Zosano Pharma
migraines
FDA
bankruptcy
After filing for bankruptcy, rejected migraine drug developer Zosano’s value more than halved
Endpoints
Thu, 06/2/22 - 12:14 pm
Zosano Pharma
migraines
layoffs
FDA
Pfizer to acquire Biohaven in $11.6B bet on biotech’s migraine drugs
BioPharma Dive
Tue, 05/10/22 - 10:57 am
Pfizer
M&A
Biohaven
migraines
No go for Zosano as FDA knockback triggers suspension of transdermal migraine patch program
Fierce Pharma
Tue, 05/3/22 - 10:44 pm
Zosano Pharma
FDA
migraines
migraine patch
M207
As expected, FDA spikes down Axsome migraine med, but issues are 'addressable'
Fierce Biotech
Mon, 05/2/22 - 06:19 pm
Axsome Therapeutics
migraines
FDA
AXS-07
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
BioSpace
Mon, 05/2/22 - 11:44 am
FDA
complete response letter
Junshi Biosciences
Coherus Biosciences
Axsome Therapeutics
migraines
AXS-07
After culling workforce, migraine biotech Zosano drops lead — and sole — program
Endpoints
Mon, 05/2/22 - 11:00 am
Zosano
migraines
layoffs
M207
Biohaven migraine drug partnered with Pfizer lands twin European approvals
MedCity News
Wed, 04/27/22 - 10:38 pm
Europe
Pfizer
Biohaven
migraines
rimegepant

Pages